Literature DB >> 15939834

Recommendations of the National Heart, Lung, and Blood Institute Working Group on Future Direction in Cardiac Surgery.

William A Baumgartner1, Stephanie Burrows, Pedro J del Nido, Timothy J Gardner, Suzanne Goldberg, Robert C Gorman, George V Letsou, Alice Mascette, Robert E Michler, John D Puskas, Eric A Rose, Todd K Rosengart, Frank W Sellke, Sara J Shumway, Norbert Wilke.   

Abstract

New surgical procedures, imaging modalities, and medical devices have improved therapy for many patients and made treatment possible for others who have had few options in the past. In February 2004, the National Heart, Lung, and Blood Institute's (NHLBI) Advisory Council proposed that the institute evaluate the status and future directions in cardiac surgery. In response to this recommendation, the NHLBI convened a working group of cardiac surgeons on May 7 and 8, 2004, to assess the state of cardiac surgery research, identify critical gaps in current knowledge, determine areas of opportunity, and obtain specific recommendations for future research activities. The working group discussed surgical revascularization, novel surgical approaches, valvular research directions, biotechnology and cell-based therapy, heart failure, imaging modalities, and barriers to clinical research and presents its recommendations here.

Entities:  

Mesh:

Year:  2005        PMID: 15939834     DOI: 10.1161/CIRCULATIONAHA.104.530154

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Revascularize only for ischemia, especially if left ventricular function is poor.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 2.  Stem cell therapy for heart failure.

Authors:  Robert E Michler
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

3.  Surgical options for the management of ischemic cardiomyopathy.

Authors:  Robert Michler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

4.  Imaging and minimally invasive aortic valve replacement.

Authors:  Gabriel Loor; Eric E Roselli
Journal:  Ann Cardiothorac Surg       Date:  2015-01

5.  Calpain inhibition decreases myocardial apoptosis in a swine model of chronic myocardial ischemia.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Jun Feng; Yuhong Liu; Hunter Mitchell; Peter Quesenberry; M Ruhul Abid; Frank W Sellke
Journal:  Surgery       Date:  2015-05-16       Impact factor: 3.982

6.  Image-Based Patient-Specific Ventricle Models with Fluid-Structure Interaction for Cardiac Function Assessment and Surgical Design Optimization.

Authors:  Dalin Tang; Chun Yang; Tal Geva; Pedro J Del Nido
Journal:  Prog Pediatr Cardiol       Date:  2010-12-01

7.  Building an infrastructure for clinical trials in cardiac surgery.

Authors:  Timothy J Gardner; Marissa A Miller; Patrick T O'Gara; Annetine C Gelijns
Journal:  J Thorac Cardiovasc Surg       Date:  2011-08       Impact factor: 5.209

8.  Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network.

Authors:  Peter K Smith; Robert E Michler; Y Joseph Woo; John H Alexander; John D Puskas; Michael K Parides; Rebecca T Hahn; Judson B Williams; John M Dent; T Bruce Ferguson; Ellen Moquete; Eric A Rose; Pierre Pagé; Neal O Jeffries; Patrick T O'Gara; Deborah D Ascheim
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-23       Impact factor: 5.209

9.  Magnesium Presence Prevents Removal of Antigenic Nuclear-Associated Proteins from Bovine Pericardium for Heart Valve Engineering.

Authors:  Ailsa J Dalgliesh; Zhi Zhao Liu; Leigh G Griffiths
Journal:  Tissue Eng Part A       Date:  2017-03-10       Impact factor: 3.845

10.  Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering.

Authors:  Peter M Crapo; Yadong Wang
Journal:  Acta Biomater       Date:  2009-11-01       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.